You are here

iX Biopharma unit obtains Australia licence to bring product testing in-house


IX Biopharma on Monday said it has obtained a licence in Australia to bring its product testing in-house, improving speed-to-market and potentially saving on testing costs.

The pharmaceutical company's wholly-owned subsidiary iX Syrinx obtained a Good Manufacturing...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to